embryoglycan
high MW polygalactosamine-type glycan released from embryonal carcinoma glycoprotein antigens by pronase; inhibits immunoprecipitation of these antigens
Networked: 6
relevant articles (0 outcomes,
1 trials/studies)
Bio-Agent Context: Research Results
Experts
Related Diseases
Related Drugs and Biologics
Related Therapies and Procedures